Trevi Therapeutics (TRVI) Insider Trading & Ownership $6.47 -0.14 (-2.12%) Closing price 04:00 PM EasternExtended Trading$6.44 -0.03 (-0.46%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Trevi Therapeutics (NASDAQ:TRVI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.37%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$932,610.25 Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TRVI Insider Buying and Selling by Quarter Remove Ads Trevi Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/21/2025Jennifer L GoodCEOSell5,263$6.58$34,630.54 3/10/2025Farrell SimonInsiderSell81,313$6.75$548,862.75 9/9/2024Jennifer L GoodCEOSell1,840$3.04$5,593.60 9/6/2024Jennifer L GoodCEOSell4,219$3.03$12,783.57 9/4/2024Jennifer L GoodCEOSell10,981$3.02$33,162.62 8/27/2024David P MeekerDirectorSell4,555$2.93$13,346.15 8/16/2024Thomas SciasciaInsiderSell18,660$2.76$51,501.60 8/14/2024Thomas SciasciaInsiderSell100$2.75$275.00 5/29/2024Thomas SciasciaInsiderSell53,368$2.55$136,088.40 5/22/2024Lisa DelfiniCFOSell4,350$2.64$11,484.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/20/2024Jennifer L GoodCEOSell25,037$2.86$71,605.82 5/10/2024Jennifer L GoodCEOSell4,578$2.90$13,276.20 (Data available from 1/1/2013 forward) TRVI Insider Trading Activity - Frequently Asked Questions Who is on Trevi Therapeutics's Insider Roster? The list of insiders at Trevi Therapeutics includes David P Meeker, Farrell Simon, Jennifer L Good, Lisa Delfini, Paul Edward Walker, Thomas Sciascia, and Tpg Gp A, Llc. Learn more on insiders at TRVI. What percentage of Trevi Therapeutics stock is owned by insiders? 24.37% of Trevi Therapeutics stock is owned by insiders. Learn more on TRVI's insider holdings. Which Trevi Therapeutics insiders have been selling company stock? The following insiders have sold TRVI shares in the last 24 months: David P Meeker ($13,346.15), Farrell Simon ($548,862.75), Jennifer L Good ($171,052.35), Lisa Delfini ($21,007.00), and Thomas Sciascia ($187,865.00). How much insider selling is happening at Trevi Therapeutics? Insiders have sold a total of 218,579 Trevi Therapeutics shares in the last 24 months for a total of $942,133.25 sold. Trevi Therapeutics Key ExecutivesMs. Jennifer L. Good (Age 59)Co-Founder, CEO, President & Director Compensation: $781.85k1 recent tradesDr. Thomas R. Sciascia M.D. (Age 71)Co-Founder & Chief Science Officer Compensation: $530.48kDr. David J. Clark A.F.P.M. (Age 59)M.D., M.R.C.P., Chief Medical Officer Compensation: $325.39kMs. Lisa Delfini (Age 54)Chief Financial Officer Mr. Christopher Galletta (Age 46)Controller & Chief Accounting Officer Katie McManusCommunications ManagerMr. Farrell Simon Pharm.D.Chief Commercial OfficerMs. Danine Summers (Age 66)Vice President of Medical Affairs More Insider Trading Tools from MarketBeat Related Companies Harmony Biosciences Insider Transactions Arcutis Biotherapeutics Insider Transactions Janux Therapeutics Insider Transactions Travere Therapeutics Insider Transactions Agios Pharmaceuticals Insider Transactions Tarsus Pharmaceuticals Insider Transactions Apogee Therapeutics Insider Transactions Vera Therapeutics Insider Transactions Disc Medicine Insider Transactions Schrödinger Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:TRVI) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
